Last reviewed · How we verify
Lenvatinib Pill
Lenvatinib Pill is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently FDA-approved. Also known as: percutaneous ablative procedure, E7080, Level 0 Lenvatinib, Level -1 Lenvatinib.
At a glance
| Generic name | Lenvatinib Pill |
|---|---|
| Also known as | percutaneous ablative procedure, E7080, Level 0 Lenvatinib, Level -1 Lenvatinib, Level -2 Lenvatinib |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Merck IIT: RRP Pembro and Lenvatinib (EARLY_PHASE1)
- Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative (PHASE2)
- Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment (PHASE2)
- Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma (PHASE1)
- Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion (PHASE2)
- Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer (PHASE1, PHASE2)
- FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation (PHASE1, PHASE2)
- Using Chronobiology to Improve Lenvatinib Efficacy (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lenvatinib Pill CI brief — competitive landscape report
- Lenvatinib Pill updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Lenvatinib Pill
What is Lenvatinib Pill?
Lenvatinib Pill is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris.
Who makes Lenvatinib Pill?
Lenvatinib Pill is developed and marketed by Assistance Publique - Hôpitaux de Paris (see full Assistance Publique - Hôpitaux de Paris pipeline at /company/assistance-publique-h-pitaux-de-paris).
Is Lenvatinib Pill also known as anything else?
Lenvatinib Pill is also known as percutaneous ablative procedure, E7080, Level 0 Lenvatinib, Level -1 Lenvatinib, Level -2 Lenvatinib.
What development phase is Lenvatinib Pill in?
Lenvatinib Pill is FDA-approved (marketed).
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Also known as: percutaneous ablative procedure, E7080, Level 0 Lenvatinib, Level -1 Lenvatinib, Level -2 Lenvatinib
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing